FKONCO

Fresenius Kabi Oncology Limited has submitted to the Exchange vide letter dated October 16, 2012 a copy Disclosure under regulation 13(6) of the SEBI (Prohibition of Insider Trading Regulations), 1992.

Fresenius Kabi (Singapore) Pte Ltd has submitted to the Exchange vide letter dated October 15, 2012 a copy of Disclosure in terms of Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 along with Regulation 13(3), 13(4), 13(4A) & 13(6) and of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dabur Pharma Limited has informed the Exchange that 1) Ratna Commercial Ent. Pvt. Ltd. has sold 2000000 shares aggregating to 1.28% of the total paid up capital of Dabur Pharma Limited on March 31, 2006 & April 03, 2006. The shareholding of Ratna Commercial Ent. Pvt. Ltd. after the said sale is 15116402 shares aggregating to 9.68% of the total paid up capital of Dabur Pharma Limited. 2) Chowdry Associates has sold 209170 shares aggregating to 0.13% of the total paid up capital of Dabur Pharma Limited on March 31, 2006. The shareholding of Chowdry Associates after the said sale is 18082695 shar

Dabur Pharma Limited has informed the Exchange that Dr. (Mrs.) Rama Mukherjee has acquired 10,800 shares aggregating to 0.006% of the total share capital of Dabur Pharma Limited on March 03, 2006. The mode of acquisition is through Market Purchase and the shareholding of Dr. (Mrs.) Rama Mukherjee after the said acquisition is 91,185 shares aggregating to 0.058% of the total share capital of Dabur Pharma Limited.

Dabur Pharma Limited has informed the Exchange that Mr. Ajay Kumar Vij, Director has acquired 46406 shares of Dabur Pharma Limited on February 14, 2006. The mode of acquisition is Direct allotment by company under ESOP Scheme 2004 pursuant to exercise of vested options and the shareholding of Mr. Ajay Kumar Vij after the said acquisition is 49006 shares aggregating to 0.031% of the share capital of Dabur Pharma Limited.

Dabur Pharma Limited has informed the Exchange that Dr. (Mrs.) Rama Mukherjee, Director of the Company, has acquired 15,000 shares on February 03, 2006. The mode of acquisition is Market Purchase and the shareholding of Dr. (Mrs.) Rama Mukherjee, after the said acquisition is 80,385 shares aggregating to 0.052% of the total share capital of the Dabur Pharma Limited.

Dabur Pharma Limited has informed the Exchange that Dr. (Mrs.) Rama Mukherjee, Director of the Company, has acquired shares of Dabur Pharma Ltd. as follows: (1) 2517 shares on September 26, 2005. (2) 12483 shares on September 27, 2005. (3) 2415 shares on September 28, 2005 (4) 3171 shares on September 29, 2005.(5)9414 shares on September 30, 2005.the mode of purchase is Market Purchase and the shareholding of Dr. (Mrs.) Rama Mukherjee, after the said acquisition is 65385 shares aggregating to 0.042% of the total share capital of the Dabur Pharma Limited.

Dabur Pharma Limited has informed the Exchange that the Compensation Committee of Directors, constituted for the purpose of grant of ESOP to the eligible employees and Directors of the Company, has granted 718,820 Options under ESOP 2004 Scheme at their meeting held on September 1, 2005.

Dabur Pharma Limited has informed the Exchange that International Finance Corporation have acquired 12,14,5000 shares aggregating to 7.788% of the total paid up capital of Dabur Pharma Ltd. on June 13, 2005 .The mode of acquisition is preferential allotment and the shareholding of International Finance Corporation after the said acquisition is 12,14,5000 shares aggregating to 7.788% of the total paid up capital of Dabur Pharma Limited.

Dabur Pharma Limited has informed the Exchange that Dr. (Mrs.) Rama Mukherjee, Director of the Company has acquired 25800 shares of Dabur Pharma Limited on March 24, 2005 .The mode of acquisition is market purchase and the shareholding of Dr. (Mrs.) Rama Mukherjee, after the said acquisition is 35385 shares aggregating to 0.024% of the share capital of Dabur Pharma Ltd..

Dabur Pharma Limited has informed the Exchange that Mr.Ajay Kumar Vij, Director of the Company has sold 7000 shares on November 24,2004 and 3000 shares on December 07,2004.The shareholding of Mr.Ajay Kumar Vij after the said sale is 4100 shares aggregating 0.0028% of shares of Dabur Pharma Ltd.

Dabur Pharma Limited has informed the Exchange that Mr.P.D.Narang, Director of the Company has sold 50900 shares during the period December 07,2004 to December 09,2004 and 25,000 shares on December 15,2004 of Dabur Pharma Limited. The shareholding of Mr.P.D.Narang after the said sale is 36244 shares aggregating 0.025% of the total shareholding of the Company.

Dabur Pharma Limited has informed the Exchange that Mr.P.D.Narang, Director of the Company has sold 20000 shares during the period December 24,2004 to December 27,2004 The shareholding of Mr.P.D.Narang after the said sale is 16244 shares aggregating 0.011% of the total shareholding of the Company.

Dabur Pharma Limited has informed the Exchange that Mr.P.D.Narang, Director of the Company has sold 10244 shares during the period December 30,2004 to December 31,2004 The shareholding of Mr.P.D.Narang after the said sale is 6000 shares aggregating 0.004% of the total shareholding of the Company.